Exelixis | Passivo Circulante

Current Liabilities Alterar Data
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
Akebia Therapeutics USD 99.87M 20.17M 2023-12
Amgen USD 18.39B 1.44B 2023-12
AstraZeneca USD 28.59B 2.21B 2023-09
Bayer EUR 33.08B 894M 2023-09
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Bluebird Bio USD 158.96M 23.94M 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Cytokinetics USD 102.68M 24.96M 2023-12
Eisai JPY 307.31B 11.44B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Esperion Therapeutics USD 137.71M 30.54M 2023-09
Exelixis USD 376.82M 37.2M 2023-09
Genmab DKK 2.9B 909M 2023-09
Incyte USD 1.24B 115.7M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Merck USD 23.09B 300M 2023-09
Moderna USD 3.02B 1.37B 2023-12
Nektar Therapeutics USD 52.11M 1.42M 2023-09
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Takeda JPY 2.37T 134.12B 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
Xencor USD 84.71M 31.67M 2023-12



Exelixis Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.